Roche Diagnostics Revenues Essentially Flat in 2022
Molecular lab revenues fell 17 percent during the year, while core lab sales were up 3 percent and point-of-care revenues grew 15 percent.
Source: genomeweb.com
Stay updated with breaking news from Cobas Pulse. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Molecular lab revenues fell 17 percent during the year, while core lab sales were up 3 percent and point-of-care revenues grew 15 percent.
Growth and new partnerships have Glytec excited for the future of its Glucommander insulin dosing decision support software.